Exclusive: Women’s health biotech Freya Biosciences raises $38M for microbial immunotherapies

2023-12-12

免疫疗法

Freya Biosciences, a Danish and US biotech named after the Norse goddess of fertility, has raised a $38 million Series A, the clinical-stage startup told Endpoints News exclusively. The Copenhagen and Boston startup, formed during the early days of the Covid-19 pandemic, will use the funding to test its investigational donor- and strain-derived microbial immunotherapies. “If we can shift the microbial ecology, we have that corresponding shift in the immune profile, which would then have an effect on these quite severe indications that are downstream of this inflammation that arises in the reproductive tract,” CEO Colleen Acosta said in an interview with Endpoints.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构